Probing the Molecular-Degree Interactions in an Lively Pharmaceutical Ingredient (API) – Polymer Dispersion and the Ensuing Affect on Drug Product Formulation.
- An investigation of underlying mechanisms of API-polymer interplay patterns has the potential to supply helpful insights for choosing applicable formulations with superior bodily stability and processability.
- On this examine, copovidone was used as a polymeric provider for a number of mannequin compounds together with clotrimazole, nifedipine, and posaconazole.
- The numerous chemical constructions conferred the power for the mannequin compounds to type distinct interactions with copovidone.
- Rheology and nuclear magnetic resonance (NMR) have been mixed to analyze the molecular sample and relative power of energetic pharmaceutical ingredient (API)-polymer interactions.
- As well as, the affect of the interactions on formulation processability through sizzling soften extrusion (HME) and bodily stability have been evaluated.The rheological response of an API-polymer system was discovered to be extremely delicate to API-polymer interplay, relying each on API chemistry and API-polymer miscibility.
- Within the techniques studied, dispersed API induced a stronger plasticizer impact on the polymer matrix in comparison with crystalline/aggregated API. Correspondingly, the processing torque through HME confirmed a proportional relationship with the utmost complicated viscosity of the API-polymer system.
- With a purpose to quantitatively consider the relative power of the API-polymer interplay, homogeneously dispersed API-polymer amorphous samples have been ready by HME at an elevated temperature.
- DSC, XRD, and rheology have been employed to substantiate the amorphous integrity and homogeneity of the resultant extrudates. Subsequently, the homogeneously dispersed API-polymer amorphous dispersions have been interrogated by rheology and NMR to supply a qualitative and quantitative evaluation of the character of the API-polymer interplay, each macroscopically and microscopically.
- Rheological grasp curves of frequency sweeps of the extrudates exhibited a robust dependence on the API chemistry and revealed a rank ordering of the relative power of API-copovidone interactions, within the order of posaconazole > nifedipine > clotrimazole.
- NMR information supplied the means to exactly map the API-polymer interplay sample and establish the precise websites of interplay from a molecular perspective. Lastly, the affect of API-polymer interactions on the bodily stability of the resultant extrudates was studied.
- Qualitative and quantitative analysis of the relative power of the API-polymer interplay was efficiently completed by using mixed rheology and NMR. Graphical Summary
allelebio
PSMB8 Antibody |
|||
| 1-CSB-PA775839 | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
|||
PSMB8 Antibody |
|||
| E043134 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
PSMB8 Antibody |
|||
| 1-CSB-PA018886GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
|||
PSMB8 Antibody |
|||
| 1-CSB-PA018886LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
PSMB8 Antibody |
|||
| E94054 | EnoGene | 100μg | EUR 255 |
|
Description: Available in various conjugation types. |
|||
PSMB8 Antibody |
|||
| E97340 | EnoGene | 100ul | EUR 255 |
|
Description: Available in various conjugation types. |
|||
PSMB8 Antibody |
|||
| E314816 | EnoGene | 100ug/200ul | EUR 295 |
|
Description: Available in various conjugation types. |
|||
PSMB8 antibody |
|||
| 70R-13550 | Fitzgerald | 100 ul | EUR 550 |
|
Description: Affinity purified Rabbit polyclonal PSMB8 antibody |
|||
PSMB8 antibody |
|||
| 70R-19589 | Fitzgerald | 50 ul | EUR 289 |
|
Description: Rabbit polyclonal PSMB8 antibody |
|||
PSMB8 Antibody |
|||
| 1-CSB-PA116429 | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
|||
PSMB8 antibody |
|||
| BF0434 | Nova Lifetech | 100ug | EUR 355 |
PSMB8 Antibody |
|||
| MBS7113266-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
| MBS7113266-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
| MBS7113266-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
| MBS7129229-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
| MBS7129229-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
| MBS7129229-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
| MBS7129230-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
| MBS7129230-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
| MBS7129230-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 antibody |
|||
| MBS9405580-01mL | MyBiosource | 0.1mL | EUR 420 |
PSMB8 antibody |
|||
| MBS9405580-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
PSMB8 Antibody |
|||
| MBS8500013-01mg | MyBiosource | 0.1mg | EUR 325 |
PSMB8 Antibody |
|||
| MBS8500013-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
PSMB8 Antibody |
|||
| MBS8500013-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
PSMB8 Antibody |
|||
| MBS8500013-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
PSMB8 Antibody |
|||
| MBS8500013-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
PSMB8 Antibody |
|||
| MBS5312424-01mL | MyBiosource | 0.1mL | EUR 1070 |
PSMB8 Antibody |
|||
| MBS5312424-5x01mL | MyBiosource | 5x0.1mL | EUR 4655 |
PSMB8 Antibody |
|||
| MBS9416351-01mL | MyBiosource | 0.1mL | EUR 305 |
PSMB8 Antibody |
|||
| MBS9416351-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
PSMB8 Antibody |
|||
| BF0434-100ul | Affinity Biosciences | 100ul | EUR 210 |
|
Description: WB,IHC,IF/ICC,ELISA |
|||
PSMB8 Antibody |
|||
| BF0434-200ul | Affinity Biosciences | 200ul | Ask for price |
|
Description: WB,IHC,IF/ICC,ELISA |
|||
PSMB8 Antibody |
|||
| BF0434-50ul | Affinity Biosciences | 50ul | EUR 150 |
|
Description: WB,IHC,IF/ICC,ELISA |
|||
PSMB8 Conjugated Antibody |
|||
| C43134 | SAB | 100ul | EUR 476.4 |
PSMB8 Polyclonal Antibody |
|||
| E-AB-92394-120uL | Elabscience Biotech | 120uL | EUR 320 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-92394-200uL | Elabscience Biotech | 200uL | EUR 530 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-92394-60uL | Elabscience Biotech | 60uL | EUR 200 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-92394-each | Elabscience Biotech | each | Ask for price |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| A73468 | EpiGentek | 50 μl | EUR 557 |
PSMB8 Polyclonal Antibody |
|||
| E-AB-61655-120uL | Elabscience Biotech | 120uL | EUR 320 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-61655-200uL | Elabscience Biotech | 200uL | EUR 530 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-61655-60uL | Elabscience Biotech | 60uL | EUR 200 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-61655-each | Elabscience Biotech | each | Ask for price |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| MBS2538339-006mL | MyBiosource | 0.06mL | EUR 190 |
PSMB8 Polyclonal Antibody |
|||
| MBS2538339-012mL | MyBiosource | 0.12mL | EUR 265 |
PSMB8 Polyclonal Antibody |
|||
| MBS2538339-02mL | MyBiosource | 0.2mL | EUR 415 |
PSMB8 Polyclonal Antibody |
|||
| MBS2538339-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-002mL | MyBiosource | 0.02mL | EUR 140 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-006mL | MyBiosource | 0.06mL | EUR 180 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-012mL | MyBiosource | 0.12mL | EUR 260 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-02mL | MyBiosource | 0.2mL | EUR 405 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-002mL | MyBiosource | 0.02mL | EUR 140 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-006mL | MyBiosource | 0.06mL | EUR 180 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-012mL | MyBiosource | 0.12mL | EUR 260 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-02mL | MyBiosource | 0.2mL | EUR 405 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
PSMB8 Polyclonal Antibody |
|||
| RD84433A-120uL | Reddot Biotech | 120μL | EUR 360 |
|
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
|||
PSMB8 Polyclonal Antibody |
|||
| RD84433A-200uL | Reddot Biotech | 200μL | EUR 630 |
|
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
|||
PSMB8 Polyclonal Antibody |
|||
| RD84433A-60uL | Reddot Biotech | 60μL | EUR 204 |
|
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
|||
PSMB8 Antibody (N-term) |
|||
| MBS9213569-008mL | MyBiosource | 0.08mL | EUR 210 |
PSMB8 Antibody (N-term) |
|||
| MBS9213569-04mL | MyBiosource | 0.4mL | EUR 430 |
PSMB8 Antibody (N-term) |
|||
| MBS9213569-5x04mL | MyBiosource | 5x0.4mL | EUR 1910 |
PSMB8 Antibody, HRP conjugated |
|||
| 1-CSB-PA018886LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
PSMB8 Antibody, HRP Conjugated |
|||
| MBS7113267-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody, HRP Conjugated |
|||
| MBS7113267-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody, HRP Conjugated |
|||
| MBS7113267-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody, FITC conjugated |
|||
| 1-CSB-PA018886LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
OACD05288-1ML - PSMB8 Antibody |
|||
| OACD05288-1ML | Aviva Systems Biology | 1ml | EUR 649 |
OACD05289-1ML - PSMB8 Antibody |
|||
| OACD05289-1ML | Aviva Systems Biology | 1ml | EUR 659 |
OACD05290-1ML - PSMB8 Antibody |
|||
| OACD05290-1ML | Aviva Systems Biology | 1ml | EUR 639 |
PSMB8 Antibody, FITC Conjugated |
|||
| MBS7113268-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody, FITC Conjugated |
|||
| MBS7113268-01mL | MyBiosource | 0.1mL | EUR 270 |
Molecular identification of dried squid merchandise bought in China utilizing DNA barcoding and SYBR inexperienced actual time PCR.
Dried squid merchandise are standard in China as a snack meals, aspect dishes, or refreshments, and the market enchantment will be mirrored by the excessive worth that often reaches 497 RMB per kg.
Nevertheless, the absence of harmonisation across the definition of squid, in addition to the issues with visible inspection for processed seafood merchandise, make different species substitution for dried squid merchandise a frequent prevalence.
The intention of the current examine was to use a DNA barcoding strategy for species identification of 48 dried squid merchandise collected from the most important on-line purchasing platform in China.
Furthermore, we additionally developed a novel SYBR inexperienced real-time PCR assay (simplex and duplex adopted by a melting curve evaluation) particular for Illex argentinus and Todarodes pacificus based mostly on cytochrome C oxidase subunit I (COI) gene.
Outcomes highlighted the profitable DNA extraction and PCR amplification of a 655 bp COI gene fragment from all merchandise.
A most similarity worth within the vary of 98-100% was obtained for all readable sequences utilizing the BOLD and BLAST public databases and 4 species (Dosidicus gigas, Uroteuthis edulis, I. argentinus, and T. pacificus) have been recognized.
The specificity of the designed primer units was confirmed towards 23 non-target species, and the newly developed strategies have been efficiently utilized to display I. argentinus and T. pacificus in dried squid merchandise.
Total, DNA barcoding is a strong device for seafood species identification and the novel methodology is efficient in screening I. argentinus and T. pacificus in meals merchandise.
PSMB8 Antibody |
|||
| 1-CSB-PA775839 | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
|||
PSMB8 Antibody |
|||
| E043134 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
PSMB8 Antibody |
|||
| 1-CSB-PA018886GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
|||
PSMB8 Antibody |
|||
| 1-CSB-PA018886LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
PSMB8 Antibody |
|||
| E94054 | EnoGene | 100μg | EUR 255 |
|
Description: Available in various conjugation types. |
|||
PSMB8 Antibody |
|||
| E97340 | EnoGene | 100ul | EUR 255 |
|
Description: Available in various conjugation types. |
|||
PSMB8 Antibody |
|||
| E314816 | EnoGene | 100ug/200ul | EUR 295 |
|
Description: Available in various conjugation types. |
|||
PSMB8 antibody |
|||
| 70R-13550 | Fitzgerald | 100 ul | EUR 550 |
|
Description: Affinity purified Rabbit polyclonal PSMB8 antibody |
|||
PSMB8 antibody |
|||
| 70R-19589 | Fitzgerald | 50 ul | EUR 289 |
|
Description: Rabbit polyclonal PSMB8 antibody |
|||
PSMB8 Antibody |
|||
| 1-CSB-PA116429 | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
|||
PSMB8 antibody |
|||
| BF0434 | Nova Lifetech | 100ug | EUR 355 |
PSMB8 Antibody |
|||
| MBS7113266-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
| MBS7113266-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
| MBS7113266-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
| MBS7129229-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
| MBS7129229-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
| MBS7129229-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody |
|||
| MBS7129230-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody |
|||
| MBS7129230-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody |
|||
| MBS7129230-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 antibody |
|||
| MBS9405580-01mL | MyBiosource | 0.1mL | EUR 420 |
PSMB8 antibody |
|||
| MBS9405580-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
PSMB8 Antibody |
|||
| MBS8500013-01mg | MyBiosource | 0.1mg | EUR 325 |
PSMB8 Antibody |
|||
| MBS8500013-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
PSMB8 Antibody |
|||
| MBS8500013-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
PSMB8 Antibody |
|||
| MBS8500013-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
PSMB8 Antibody |
|||
| MBS8500013-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
PSMB8 Antibody |
|||
| MBS5312424-01mL | MyBiosource | 0.1mL | EUR 1070 |
PSMB8 Antibody |
|||
| MBS5312424-5x01mL | MyBiosource | 5x0.1mL | EUR 4655 |
PSMB8 Antibody |
|||
| MBS9416351-01mL | MyBiosource | 0.1mL | EUR 305 |
PSMB8 Antibody |
|||
| MBS9416351-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
PSMB8 Antibody |
|||
| BF0434-100ul | Affinity Biosciences | 100ul | EUR 210 |
|
Description: WB,IHC,IF/ICC,ELISA |
|||
PSMB8 Antibody |
|||
| BF0434-200ul | Affinity Biosciences | 200ul | Ask for price |
|
Description: WB,IHC,IF/ICC,ELISA |
|||
PSMB8 Antibody |
|||
| BF0434-50ul | Affinity Biosciences | 50ul | EUR 150 |
|
Description: WB,IHC,IF/ICC,ELISA |
|||
PSMB8 Conjugated Antibody |
|||
| C43134 | SAB | 100ul | EUR 476.4 |
PSMB8 Polyclonal Antibody |
|||
| E-AB-92394-120uL | Elabscience Biotech | 120uL | EUR 320 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-92394-200uL | Elabscience Biotech | 200uL | EUR 530 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-92394-60uL | Elabscience Biotech | 60uL | EUR 200 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-92394-each | Elabscience Biotech | each | Ask for price |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| A73468 | EpiGentek | 50 μl | EUR 557 |
PSMB8 Polyclonal Antibody |
|||
| E-AB-61655-120uL | Elabscience Biotech | 120uL | EUR 320 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-61655-200uL | Elabscience Biotech | 200uL | EUR 530 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-61655-60uL | Elabscience Biotech | 60uL | EUR 200 |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| E-AB-61655-each | Elabscience Biotech | each | Ask for price |
|
Description: Unconjugated |
|||
PSMB8 Polyclonal Antibody |
|||
| MBS2538339-006mL | MyBiosource | 0.06mL | EUR 190 |
PSMB8 Polyclonal Antibody |
|||
| MBS2538339-012mL | MyBiosource | 0.12mL | EUR 265 |
PSMB8 Polyclonal Antibody |
|||
| MBS2538339-02mL | MyBiosource | 0.2mL | EUR 415 |
PSMB8 Polyclonal Antibody |
|||
| MBS2538339-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-002mL | MyBiosource | 0.02mL | EUR 140 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-006mL | MyBiosource | 0.06mL | EUR 180 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-012mL | MyBiosource | 0.12mL | EUR 260 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-02mL | MyBiosource | 0.2mL | EUR 405 |
PSMB8 Polyclonal Antibody |
|||
| MBS2527805-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-002mL | MyBiosource | 0.02mL | EUR 140 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-006mL | MyBiosource | 0.06mL | EUR 180 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-012mL | MyBiosource | 0.12mL | EUR 260 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-02mL | MyBiosource | 0.2mL | EUR 405 |
PSMB8 Polyclonal Antibody |
|||
| MBS2528965-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
PSMB8 Conjugated Antibody |
|||
| MBS9451453-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
PSMB8 Polyclonal Antibody |
|||
| RD84433A-120uL | Reddot Biotech | 120μL | EUR 360 |
|
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
|||
PSMB8 Polyclonal Antibody |
|||
| RD84433A-200uL | Reddot Biotech | 200μL | EUR 630 |
|
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
|||
PSMB8 Polyclonal Antibody |
|||
| RD84433A-60uL | Reddot Biotech | 60μL | EUR 204 |
|
Description: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit. |
|||
PSMB8 Antibody (N-term) |
|||
| MBS9213569-008mL | MyBiosource | 0.08mL | EUR 210 |
PSMB8 Antibody (N-term) |
|||
| MBS9213569-04mL | MyBiosource | 0.4mL | EUR 430 |
PSMB8 Antibody (N-term) |
|||
| MBS9213569-5x04mL | MyBiosource | 5x0.4mL | EUR 1910 |
PSMB8 Antibody, HRP conjugated |
|||
| 1-CSB-PA018886LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
PSMB8 Antibody, HRP Conjugated |
|||
| MBS7113267-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody, HRP Conjugated |
|||
| MBS7113267-01mL | MyBiosource | 0.1mL | EUR 270 |
PSMB8 Antibody, HRP Conjugated |
|||
| MBS7113267-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
PSMB8 Antibody, FITC conjugated |
|||
| 1-CSB-PA018886LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
OACD05288-1ML - PSMB8 Antibody |
|||
| OACD05288-1ML | Aviva Systems Biology | 1ml | EUR 649 |
OACD05289-1ML - PSMB8 Antibody |
|||
| OACD05289-1ML | Aviva Systems Biology | 1ml | EUR 659 |
OACD05290-1ML - PSMB8 Antibody |
|||
| OACD05290-1ML | Aviva Systems Biology | 1ml | EUR 639 |
PSMB8 Antibody, FITC Conjugated |
|||
| MBS7113268-005mL | MyBiosource | 0.05mL | EUR 190 |
PSMB8 Antibody, FITC Conjugated |
|||
| MBS7113268-01mL | MyBiosource | 0.1mL | EUR 270 |